Generic Drug Market in Canada

Publication Date	August 2009
Publisher	RNCOS
Product Type	Report
Pages	85
ISBN Number	not applicable
Product Code	RCS00395

Buy this product or for assistance call +44 20 7060 7474

PDF £720.00$1198 | €806

PRINT £840.00$1397 | €940

CD-ROM £840.00$1397 | €940

FAX Order above formats by FAX

Summary

Canada represents one of the largest markets for pharmaceuticals in the world, with a huge potential for generics. In 2008, generics accounted for more than 51% prescriptions and around 23% sales of the total pharmaceutical market. The Canadian generics market is benefitting from several factors such as patent expiry of several blockbuster drugs, lower costs, cost containment measures by the government and rapidly ageing population, according to Generic Drug Market in Canada, a comprehensive market research report by RNCOS.

The report thoroughly evaluates factors that distinguish Canada from other generics markets both in positive and negative ways. A major factor that differentiates the Canadian generics market from the US and most European markets is comparatively higher prices of generics and lower price erosion. As this characteristic of the market allows manufacturers to fetch better margins from their drugs, many foreign players have shown keen interest to enter the Canadian generics market to make most of this lucrative characteristic.

At present, drugs to treat chronic diseases account for most of the pharmaceutical market, with cardiovascular drugs holding the top spot. However, strong growth is expected in other chronic segments, particularly in cancer and diabetes.

Although the Canadian generics market has huge growth potential, recent government regulations and various other challenges can significantly hamper the development of the market. However, low cost of generics and billion dollar drug patent expiries will enable the generics market to continue its double-digit growth in the next five years.

Content

1. Analyst View
2. Macroeconomic and Healthcare Factors
- 2.1 Macroeconomic Indicators
- 2.2 Population Profile
- 2.3 Age Profile
- 2.4 Healthcare Spending and Infrastructure
3. Pharmaceutical Market
- 3.1 Market Size and Growth
  - 3.1.1 Prescriptions
  - 3.1.2 Sales
- 3.2 By Therapeutic Category
- 3.3 By Drug Category
- 3.4 Healthcare Expenditure
- 3.5 Top Selling Drugs
  - 3.5.1 Prescriptions
  - 3.5.2 Sales
4. Generics Market Attractions
- 4.1 Favorable Political Environment
- 4.2 Aging Population
- 4.3 Patent Expiration
- 4.4 High Returns for Pharmacists
- 4.5 Huge Cost Savings
5. Generics Market
- 5.1 Market Size and Growth
  - 5.1.1 Prescriptions
  - 5.1.2 Sales
- 5.2 By Province/Territories
  - 5.2.1 Drug Consumption
  - 5.2.2 Prescriptions
  - 5.2.3 Sales
- 5.3 Market Segmentation
  - 5.3.1 Retail Pharmacies
    - 5.3.1.1 Sales
  - 5.3.2 Hospital Pharmacies
    - 5.3.2.1 Sales
  - 5.3.3 Authorized and Independent Generics
  - 5.3.4 Distribution Channels
6. Generics Market - Opportunity Areas
- 6.1 Cardiovascular Drugs
- 6.2 Psytherapeutics
- 6.3 Cholesterol Agents
- 6.4 Antidiabetics
7. Forecast for Branded and Generic Drug to 2013
8. Key Players
- 8.1 Pharmaceutical Market
  - 8.1.1 Prescriptions
  - 8.1.2 Sales
- 8.2 Generics Market
  - 8.2.1 Prescriptions
  - 8.2.2 Sales
  - 8.2.3 Retail Pharmacies
  - 8.2.4 Hospital Pharmacies
9. General Approval Process
- 9.1 Abbreviated New Drug Submission
- 9.2 Notice of Allegation
10. Industry Roadblock
- 10.1 Extension of Data Exclusivity
- 10.2 Ever-greening of Drug Patents
- 10.3 Authorized Generics
List of Figures:
- Figure 2-1: Nominal GDP (Billion US$), 2002-2008
- Figure 2-2: Consumer Price Index (%), 2002-2008
- Figure 2-3: Forecast for Consumer Price Index (%), 2009-2013
- Figure 2-4: Currency Exchange Rate (From CAD to US$), 2002-2008
- Figure 2-5: Population (Million), 2002-2008
- Figure 2-6: Forecast for Population (Million), 2009-2013
- Figure 2-7: Life Expectancy (Years), 2002-2008
- Figure 2-8: Forecast for Life Expectancy (Years), 2009-2013
- Figure 2-9: Population Breakup by Age Group (%), 2002-2008
- Figure 2-10: Forecast for Population Breakup by Age Group (%), 2009-2013
- Figure 2-11: Per Head Healthcare Spending (US$), 2002-2008
- Figure 2-12: Forecast for Per Head Healthcare Spending (US$), 2009-2013
- Figure 2-13: Number of Doctors (per '000 Population), 2002-2008
- Figure 2-14: Forecast for Number of Doctors (2009-2013)
- Figure 2-15: Number of Hospital Beds (per '000 Population), 2002-2008
- Figure 2-16: Forecast for Number of Hospital Beds (per '000 Population), 2009-2013
- Figure 3-1: Prescriptions Dispensed in Pharmaceutical Market (Million), 2007 & 2008
- Figure 3-2: Pharmaceutical Sales (Billion CAD), 2005-2008
- Figure 3-3: Pharmaceutical Purchases by Retail and Hospital Pharmacies (Billion CAD), 2005-2008
- Figure 3-4: Deaths by Various Causes (%), 2005 & 2008
- Figure 3-5: Share of Generic and Branded Drug by Prescription (2008)
- Figure 3-6: Share of Generic and Branded Drug by Sales (2008)
- Figure 3-7: Drug Financing by Source (%), 2008
- Figure 4-1: Population above 65 Years of Age (Million), 2002-2008
- Figure 4-2: Average Cost of Branded and Generic Drug (CAD), 2002-2008
- Figure 5-1: Prescriptions Dispensed in Branded Drug Market (Million), 2002-2008
- Figure 5-2: Prescriptions Dispensed in Generic Drug Market (Million), 2002-2008
- Figure 5-3: Share of Generic and Branded Drug by Prescription (2002-2008)
- Figure 5-4: Generic Drug Sales (Billion CAD), 2002-2008
- Figure 5-5: Branded Drug Sales (Billion CAD), 2002-2008
- Figure 5-6: Share of Generic and Branded Drug by Sales (2002-2008)
- Figure 5-7: Branded Drug Sales through Retail Pharmacies (Billion CAD), 2005-2008
- Figure 5-8: Generic Drug Sales through Retail Pharmacies (Billion CAD), 2005-2008
- Figure 5-9: Share of Generic and Branded Drug Sales through Retail Pharmacies (2005-2008)
- Figure 5-10: Branded Drug Sales through Hospital Pharmacies (Billion CAD), 2005-2008
- Figure 5-11: Generic Drug Sales through Hospital Pharmacies (Billion CAD), 2005-2008
- Figure 5-12: Share of Generic and Branded Drug Sales through Hospital Pharmacies (2005-2008)
- Figure 5-13: Share of Independent Generic and Authorized Generic Prescriptions (2002-2008)
- Figure 5-14: Generic Drug Market by Retail and Hospital Sales (%), 2008
- Figure 6-1: Cardiovascular Drug Market (Billion CAD), 2005-2008 & 2013
- Figure 6-2: Psychotherapeutics Market (Billion CAD), 2005-2008 & 2013
- Figure 6-3: Cholesterol Agents Market (Billion CAD), 2005-2008 & 2013
- Figure 6-4: Number of Diabetes Patients in Age Group 20-79 Years ('000), 2003, 2008 & 2025
- Figure 6-5: Diabetes Therapy Market (Million CAD), 2005-2008 & 2013
- Figure 7-1: Forecast for Pharmaceutical Sales (Billion CAD), 2009-2013
- Figure 7-2: Forecast for Generic Drug Sales (Billion CAD), 2009-2013
- Figure 7-3: Forecast for Branded Drug Sales (Billion CAD), 2009-2013
- Figure 7-4: Forecast for Share of Branded and Generic Drugs by Prescription (2009-2013)
- Figure 7-5: Forecast for Share of Branded and Generic Drugs by Sales (2009-2013)
- Figure 7-6: Forecast for Contribution of Branded and Generic Drug Sales in Growth of Pharmaceutical Market (%), 2009 to 2013
- Figure 8-1: Relation between Brand Sales and Number of Generic Entrants
List of Tables:
- Table 3-1: Top Ten Therapy Areas by Prescription ('000), 2008
- Table 3-2: Top Ten Therapy Areas by Sales ('000 CAD), 2008
- Table 3-3: Top Twenty Drugs in Pharmaceutical Market by Prescription (Million), 2008
- Table 3-4: Top Ten Drugs in Pharmaceutical Market by Sales (Million CAD), 2007
- Table 4-1: Generic and Branded Drug Returns for Pharmacists (CAD)
- Table 5-1: Per Capita Drug Spending of Public and Private Sector by Region (CAD), 2008
- Table 5-2: Generic Drug Prescriptions Dispensed by Region (%), 2002-2008
- Table 5-3: Generic Drug Sales by Region (%), 2004 & 2006
- Table 5-4: Number of Retail Pharmacies by Category (2002-2008)
- Table 5-5: Top Ten Therapy Areas by Hospital Sales (Million CAD), 2008
- Table 5-6: Pharmaceutical Sales by Distribution Channel (%), 2002-2006
- Table 8-1: Top Pharmaceutical Companies by Retail Prescription (Million), 2006
- Table 8-2: Ranking of Top Pharmaceutical Companies by Retail Prescription (2004-2006)
- Table 8-3: Top Pharmaceutical Companies by Sales (Million CAD), 2008
- Table 8-4: Ranking of Top Pharmaceutical Companies by Sales (2006-2008)
- Table 8-5: Top Generic Drug Companies by Prescription (Million), 2007
- Table 8-6: Ranking of Top Generic Drug Companies by Prescription (2005-2007)
- Table 8-7: Top Generic Drug Companies by Sales (Million CAD), 2007
- Table 8-8: Ranking of Top Generic Drug Companies by Sales (2005-2007)
- Table 8-9: Ranking of Top Generic Companies by Retail Sales (2007)
- Table 8-10: Ranking of Top Generic Companies by Hospital Sales (2006)